An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
Clinical trial NCT01202227 · COMPLETED
Trial details
- NCT number
- NCT01202227
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-03-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.